Pharvaris (PHVS) Shares Outstanding (Diluted Average) (2023 - 2025)
Pharvaris (PHVS) reported Shares Outstanding (Diluted Average) of $1901.7 for Q2 2025, up 65.04% on a YoY basis from $1152.3 in Q2 2024, and up 65.04% quarter-over-quarter from $1152.3 in Q2 2024.
Pharvaris (PHVS) Shares Outstanding (Diluted Average) (2023 - 2025) Analysis & Trends
Pharvaris has reported Shares Outstanding (Diluted Average) for 3 years, with the latest figure at $1901.7 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 92.44 Mn |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,901.69 |
| Jun 30, 2024 | 1,152.27 |
| Jun 30, 2023 | 1,415.60 |